Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06899165
PHASE2

Psilocybin-Assisted Therapy for Intergenerational Trauma

Sponsor: Rachel Yehuda

View on ClinicalTrials.gov

Summary

This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.

Official title: Processing Intergenerational Trauma With Psilocybin-Assisted Therapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-08-28

Completion Date

2030-01-02

Last Updated

2025-09-08

Healthy Volunteers

No

Interventions

DRUG

Psilocybin

Psilocybin 25mg, capsules taken orally under the supervision of two trained study therapists

BEHAVIORAL

Integration sessions

weekly integration sessions (therapy) for 6 weeks

Locations (1)

The Parsons Research Center for Psychedelic Healing

New York, New York, United States